The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
April 27th 2025
Zoldonrasib, a novel oral KRAS G12D-selective inhibitor, demonstrated promising safety and early antitumor activity in patients with previously treated non–small cell lung cancer (NSCLC), offering a potential new targeted therapy for this underserved population.
Survey Finds Younger Generations Have Least Amount of Trust in COVID-19 Vaccine
December 23rd 2020Emphasizing the importance of the COVID-19 vaccine to younger generations and those with no underlying health conditions could significantly increase the overall rate of vaccination in the United States.
Read More
European Medicines Committee Issues Positive Opinion for COVID-19 Vaccine From Pfizer, BioNTech
December 21st 2020The action allows for medicinal products to be authorized on a conditional basis for seriously debilitating or life-threatening diseases or for use in emergency situations in response to public health threats in the European Union.
Read More
FDA Approves Selinexor Combination Treatment for Certain Patients With Multiple Myeloma
December 19th 2020Selinexor (Xpovio; Karyopharm Therapeutics Inc.) in combination with bortezomib (Velcade; Takeda) and dexamethasone was approved for the treatment of adult patients with multiple myeloma who have received at least 1 prior therapy.
Read More
How the CDC’s COVID-19 Pharmacy Partnership for Long-Term Care Program Will Benefit 3 Groups
December 19th 2020Throughout the pandemic, we have taken an aggressive approach to service and safety, ensuring that there would be no disruption in services, and even expanding our offerings during these difficult times to include virtual onboarding and contactless delivery.
Read More
Understanding the 340B Prime Vendor Program and Supporting Stakeholders During COVID-19
December 15th 2020Under the 340B Prime Vendor Program, the Prime Vendor has several functions that it carries out to support stakeholders in operating and navigate the field so that they can effectively achieve lower 340B drug pricing for those who need it most.
Read More
Utilizing Education and Machine Learning to Establish an Opioid Prescription Stewardship Program
December 14th 2020Monitoring outpatient prescribing patterns has been a major challenge for the Lifespan health system in Rhode Island, since it has over 1.5 million electronic prescriptions written annually.
Read More
Study: Delirium Can Signal COVID-19 in Older, Asymptomatic Patients in Emergency Department
December 8th 2020Delirium was the sixth most common presenting symptom in all patients, suggesting the clinical importance of including delirium on checklists of presenting signs and symptoms for COVID-19.
Read More
The Importance of Conducting PrEP Counseling With a Sex Positive Approach
December 8th 2020At the virtual 2020 ASHP Midyear Clinical Meeting and Exhibition, Elyse Tung, PharmD, BCACP, discussed key counseling points for pharmacists to address with patients when prescribing and managing PrEP.
Read More
Pharmacists Address Pediatrician, Anti-Vaxxer Concerns Over Childhood Vaccinations
December 3rd 2020Following authorization allowing pharmacists to administer childhood vaccines, some pediatricians have expressed concerns that this deprives children of medical care or could lead to missed vaccines.
Read More
New Optical Method Could Enable Cancer Biomarker Breath Test
December 1st 2020The new optical sensing method is based on multi-pass spectroscopy and can detect the presence of 1 molecule of formaldehyde in a million air particles, or 1 part per million, even in the presence of gasses that often interfere with optical measurements.
Read More